Tuesday, October 4, 2016 Daily Archives

Bio-Rad Launches Nuviaâ„¢ IMAC Affinity Resin for Process Scale Purifications at Bioprocess International Conference and Exhibition 2016

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) released Nuviaâ„¢ IMAC Resin, an immobilized metal affinity chromatography resin optimized for use from lab scale through pilot studies to process-scale manufacturing, at the 2016 Bioprocess International Conference and Exhibition, Boston, Oct. 4–7. Bio-Rad (Booth #1129) will also exhibit a host of customizable workflows designed to simplify and speed up drug discovery and development, including automated multicolumn protein purification, host cell protein and host cell DNA analysis, and CRISPR/Cas9 transfection and monitoring. A…

Biologics candidate manufactured using Ajinomoto Co., Inc.’s CORYNEX® Protein Expression System enters clinical trials for the first time

Ajinomoto Althea, Inc. (“Altheaâ€) announced that a biologics candidate developed by a Japanese global pharmaceutical company and manufactured at Ajinomoto Althea using CORYNEX® Protein Expression System, has entered phase I clinical trials. The CORYNEX® system of Ajinomoto Co., Inc. (“Ajinomoto Co.â€) is a proprietary protein expression platform that combines the best attributes of mammalian and microbial systems. It greatly simplifies the processes to produce and purify recombinant proteins resulting in reduced production costs and greatly speed time to market. The…